KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
-21.29%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(-23%)
Cap. Flow
-$26.5M
Cap. Flow
% of AUM
-2.27%
Top 10 Holdings %
Top 10 Hldgs %
74.05%
Holding
36
New
5
Increased
14
Reduced
4
Closed
3
Top Buys
| 1 |
Vaxcyte
PCVX
|
$32.6M |
| 2 |
Celldex Therapeutics
CLDX
|
$26.1M |
| 3 |
Vera Therapeutics
VERA
|
$22.6M |
| 4 |
Legend Biotech
LEGN
|
$20.7M |
| 5 |
Viridian Therapeutics
VRDN
|
$18.5M |
Top Sells
| 1 |
Natera
NTRA
|
$121M |
| 2 |
Dynavax Technologies
DVAX
|
$51.1M |
| 3 |
Liquidia Corp
LQDA
|
$24.1M |
| 4 |
TSVT
2seventy bio
TSVT
|
$17.5M |
| 5 |
Protagonist Therapeutics
PTGX
|
$15.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $165M | 13.87% | 1,167,570 -854,528 | -42% | -$121M |
|
|
2
Vaxcyte
PCVX
$4B
| $121M | 10.15% | 3,200,000 +863,204 | +37% | +$32.6M |
|
|
3
Celldex Therapeutics
CLDX
$1.47B
| $118M | 9.91% | 6,500,000 +1,435,793 | +28% | +$26.1M |
|
4
Syndax Pharmaceuticals
SNDX
$1.41B
| $105M | 8.79% | 8,520,000 | – | – |
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $67M | 5.63% | 8,928,523 -156,845 | -2% | -$1.18M |
|
6
CG Oncology
CGON
$2.04B
| $64M | 5.37% | 2,611,662 +91,957 | +4% | +$2.25M |
|
|
7
Viridian Therapeutics
VRDN
$1.5B
| $63.4M | 5.32% | 4,700,000 +1,373,738 | +41% | +$18.5M |
|
|
8
Vera Therapeutics
VERA
$1.38B
| $57.6M | 4.84% | 2,400,000 +942,090 | +65% | +$22.6M |
|
9
Cogent Biosciences
COGT
$1.69B
| $54.5M | 4.58% | 9,105,000 | – | – |
|
10
Immunocore
IMCR
$1.62B
| $50.3M | 4.23% | 1,695,576 +470,000 | +38% | +$13.9M |
|
11
Beam Therapeutics
BEAM
$1.66B
| $49.2M | 4.13% | 2,518,170 +762,012 | +43% | +$14.9M |
|
12
Wave Life Sciences
WVE
$1.53B
| $39.6M | 3.33% | 4,899,497 | – | – |
|
|
13
Dynavax Technologies
DVAX
$1.19B
| $34M | 2.86% | 2,620,797 -3,940,038 | -60% | -$51.1M |
|
14
Travere Therapeutics
TVTX
$1.56B
| $32.3M | 2.71% | 1,802,750 | – | – |
|
15
Tyra Biosciences
TYRA
$675M
| $22.4M | 1.88% | 2,406,067 +1,875,589 | +354% | +$17.4M |
|
16
enGene Holdings
ENGN
$236M
| $22.4M | 1.88% | 4,994,090 | – | – |
|
|
17
Legend Biotech
LEGN
$6.41B
| $20.7M | 1.74% | +610,000 | New | +$20.7M |
|
18
Cullinan Oncology
CGEM
$445M
| $17.7M | 1.49% | 2,338,629 +1,085,891 | +87% | +$8.22M |
|
19
Nurix Therapeutics
NRIX
$714M
| $9.5M | 0.8% | +800,000 | New | +$9.5M |
|
|
20
Liquidia Corp
LQDA
$2.38B
| $9.35M | 0.79% | 633,802 -1,632,526 | -72% | -$24.1M |
|
21
Ironwood Pharmaceuticals
IRWD
$214M
| $8.56M | 0.72% | 5,822,938 +1,137,375 | +24% | +$1.67M |
|
22
Relay Therapeutics
RLAY
$619M
| $8.03M | 0.67% | 3,063,292 +2,063,292 | +206% | +$5.41M |
|
23
Geron
GERN
$893M
| $5.82M | 0.49% | +3,659,526 | New | +$5.82M |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| $5.56M | 0.47% | 12,414,628 | – | – |
|
|
BNR
25
Burning Rock Biotech
BNR
$93.6M
| $4.38M | 0.37% | 994,883 | – | – |
|